Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Methods Mol Biol ; 1527: 251-269, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28116722

RESUMO

This chapter outlines protocols to evaluate protein localization, recruitment or phosphorylation levels in cholesterol/sphingolipids-enriched cell membrane domains and recommends experimental designs with pharmacological tolls to evaluate potential cell functions associated with these domains. We emphasize the need for the combination of several approaches towards understanding the protein components and cellular functions attributed to these distinct microdomains.


Assuntos
Cavéolas/metabolismo , Microdomínios da Membrana/metabolismo , Animais , Carbonatos/metabolismo , Membrana Celular/metabolismo , Colesterol/química , Colesterol/metabolismo , Eletroforese em Gel de Poliacrilamida , Concentração de Íons de Hidrogênio , Microdomínios da Membrana/química , Músculo Liso Vascular/citologia , Miócitos de Músculo Liso/metabolismo , Ratos , Esfingolipídeos/química , Esfingolipídeos/metabolismo , beta-Ciclodextrinas/química , beta-Ciclodextrinas/metabolismo
2.
J Mol Cell Cardiol ; 66: 18-26, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24445059

RESUMO

Fat1 is an atypical cadherin that controls vascular smooth muscle cell (VSMC) proliferation and migration. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 1 (Nox1) is an important source of reactive oxygen species (ROS) in VSMCs. Angiotensin II (Ang II) induces the expression and/or activation of both Fat1 and Nox1 proteins. This study tested the hypothesis that Ang II-induced Fat1 activation and VSMC migration are mediated by Nox1-dependent ROS generation and redox signaling. Studies were performed in cultured VSMCs from Sprague­Dawley rats. Cells were treated with Ang II (1 µmol/L) for short (5 to 30 min) or long term stimulations (3 to 12 h) in the absence or presence of the antioxidant apocynin (10 µmol/L), extracellular-signal-regulated kinases 1/2 (Erk1/2) inhibitor PD98059 (1 µmol/L), or Ang II type 1 receptor (AT1R) valsartan (1 µmol/L). siRNA was used to knockdown Nox1 or Fat1. Cell migration was determined by Boyden chamber assay. Ang II increased Fat1 mRNA and protein levels and promoted Fat1 translocation to the cell membrane, responses that were inhibited by AT1R antagonist and antioxidant treatment. Downregulation of Nox1 inhibited the effects of Ang II on Fat1 protein expression. Nox1 protein induction, ROS generation, and p44/p42 MAPK phosphorylation in response to Ang II were prevented by valsartan and apocynin, and Nox1 siRNA inhibited Ang II-induced ROS generation. Knockdown of Fat1 did not affect Ang II-mediated increases in Nox1 expression or ROS. Inhibition of p44/p42 MAPK phosphorylation by PD98059 abrogated the Ang II-induced increase in Fat1 expression and membrane translocation. Knockdown of Fat1 inhibited Ang II-induced VSMC migration, which was also prevented by valsartan, apocynin, PD98059, and Nox1 siRNA. Our findings indicate that Ang II regulates Fat1 expression and activity and induces Fat1-dependent VSMC migration via activation of AT1R, ERK1/2, and Nox1-derived ROS, suggesting a role for Fat1 downstream of Ang II signaling that leads to vascular remodeling.


Assuntos
Angiotensina II/farmacologia , Caderinas/genética , Músculo Liso Vascular/efeitos dos fármacos , Miócitos de Músculo Liso/efeitos dos fármacos , NADH NADPH Oxirredutases/genética , Acetofenonas/farmacologia , Angiotensina II/metabolismo , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Animais , Antioxidantes/farmacologia , Caderinas/agonistas , Caderinas/antagonistas & inibidores , Caderinas/metabolismo , Movimento Celular/efeitos dos fármacos , Células Cultivadas , Flavonoides/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Masculino , Proteína Quinase 1 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 1 Ativada por Mitógeno/genética , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteína Quinase 3 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 3 Ativada por Mitógeno/genética , Proteína Quinase 3 Ativada por Mitógeno/metabolismo , Músculo Liso Vascular/citologia , Músculo Liso Vascular/metabolismo , Miócitos de Músculo Liso/citologia , Miócitos de Músculo Liso/metabolismo , NADH NADPH Oxirredutases/metabolismo , NADPH Oxidase 1 , Oxirredução , Inibidores de Proteínas Quinases/farmacologia , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/metabolismo , Ratos , Ratos Sprague-Dawley , Espécies Reativas de Oxigênio/metabolismo , Transdução de Sinais , Tetrazóis/farmacologia , Valina/análogos & derivados , Valina/farmacologia , Valsartana
3.
Am J Physiol Renal Physiol ; 299(6): F1348-58, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20630933

RESUMO

Molecular mechanisms underlying renal complications of diabetes remain unclear. We tested whether renal NADPH oxidase (Nox) 4 contributes to increased reactive oxygen species (ROS) generation and hyperactivation of redox-sensitive signaling pathways in diabetic nephropathy. Diabetic mice (db/db) (20 wk) and cultured mouse proximal tubule (MPT) cells exposed to high glucose (25 mmol/l, D-glucose) were studied. Expression (gene and protein) of Nox4, p22(phox), and p47(phox), but not Nox1 or Nox2, was increased in kidney cortex, but not medulla, from db/db vs. control mice (db/m) (P < 0.05). ROS generation, p38 mitogen-activated protein (MAP) kinase phosphorylation, and content of fibronectin and transforming growth factor (TGF)-ß1/2 were increased in db/db vs. db/m (P < 0.01). High glucose increased expression of Nox4, but not other Noxes vs. normal glucose (P < 0.05). This was associated with increased NADPH oxidase activation and enhanced ROS production. Nox4 downregulation by small-interfering RNA and inhibition of Nox4 activity by GK-136901 (Nox1/4 inhibitor) attenuated d-glucose-induced NADPH oxidase-derived ROS generation. High d-glucose, but not l-glucose, stimulated phosphorylation of p38MAP kinase and increased expression of TGF-ß1/2 and fibronectin, effects that were inhibited by SB-203580 (p38MAP kinase inhibitor). GK-136901 inhibited d-glucose-induced actions. Our data indicate that, in diabetic conditions: 1) renal Nox4 is upregulated in a cortex-specific manner, 2) MPT cells possess functionally active Nox4-based NADPH, 3) Nox4 is a major source of renal ROS, and 4) activation of profibrotic processes is mediated via Nox4-sensitive, p38MAP kinase-dependent pathways. These findings implicate Nox4-based NADPH oxidase in molecular mechanisms underlying fibrosis in type 2 diabetic nephropathy.


Assuntos
Diabetes Mellitus Experimental/metabolismo , Nefropatias Diabéticas/metabolismo , Rim/metabolismo , NADPH Oxidases/fisiologia , Animais , Células Cultivadas , Grupo dos Citocromos b/biossíntese , Diabetes Mellitus Experimental/patologia , Nefropatias Diabéticas/patologia , Fibrose , Glucose/farmacologia , Masculino , Camundongos , NADPH Oxidase 4 , NADPH Oxidases/biossíntese , Estresse Oxidativo/efeitos dos fármacos , Pirazóis/farmacologia , Piridonas/farmacologia , RNA Interferente Pequeno/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/efeitos dos fármacos
4.
Arterioscler Thromb Vasc Biol ; 28(8): 1511-8, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18467645

RESUMO

OBJECTIVE: Synergistic interactions between aldosterone (Aldo) and angiotensin II (Ang II) have been implicated in vascular inflammation, fibrosis, and remodeling. Molecular mechanisms underlying this are unclear. We tested the hypothesis that c-Src activation, through receptor tyrosine kinase transactivation, is critically involved in synergistic interactions between Aldo and Ang II and that it is upstream of promigratory signaling pathways in vascular smooth muscle cells (VSMCs). METHODS AND RESULTS: VSMCs from WKY rats were studied. At low concentrations (10(-10) mol/L) Aldo and Ang II alone did not influence c-Src activation, whereas in combination they rapidly increased phosphorylation (P<0.01), an effect blocked by eplerenone (Aldo receptor antagonist) and irbesartan (AT1R blocker). This synergism was attenuated by AG1478 and AG1296 (inhibitors of EGFR and PDGFR, respectively), but not by AG1024 (IGFR inhibitor). Aldo and Ang II costimulation induced c-Src-dependent activation of NAD(P)H oxidase and c-Src-independent activation of ERK1/2 (P<0.05), without effect on ERK5, p38MAPK, or JNK. Aldo/Ang II synergistically activated RhoA/Rho kinase and VSMC migration, effects blocked by PP2, apocynin, and fasudil, inhibitors of c-Src, NADPH oxidase, and Rho kinase, respectively. CONCLUSIONS: Aldo/Ang II synergistically activate c-Src, an immediate signaling response, through EGFR and PDGFR, but not IGFR transactivation. This is associated with activation of redox-regulated RhoA/Rho kinase, which controls VSMC migration. Although Aldo and Ang II interact to stimulate ERK1/2, such effects are c-Src-independent. These findings indicate differential signaling in Aldo-Ang II crosstalk and highlight the importance of c-Src in redox-sensitive RhoA, but not ERK1/2 signaling. Blockade of Aldo/Ang II may be therapeutically useful in vascular remodeling associated with abnormal VSMC migration.


Assuntos
Aldosterona/fisiologia , Angiotensina II/fisiologia , Movimento Celular/fisiologia , Músculo Liso Vascular/fisiologia , Miócitos de Músculo Liso/fisiologia , Animais , Células Cultivadas , Masculino , Ratos , Transdução de Sinais/fisiologia , Proteína rhoA de Ligação ao GTP/fisiologia , Quinases da Família src/fisiologia
5.
Arterioscler Thromb Vasc Biol ; 27(9): 1960-7, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17569879

RESUMO

OBJECTIVE: Endothelin-1 (ET-1) and angiotensin II (Ang II) activate common signaling pathways to promote changes in vascular reactivity, remodeling, inflammation, and oxidative stress. Here we sought to determine whether upstream regulators of mitogen-activated protein kinases (MAPKs) are differentially regulated by ET-1 and Ang II focusing on the role of c-Src and the small GTPase Ras. METHODS AND RESULTS: Mesenteric vascular smooth muscle cells (VSMCs) from mice with different disruption levels in the c-Src gene (c-Src(+/-) and c-Src(-/-)) and wild-type (c-Src(+/+)) were used. ET-1 and Ang II induced extracellular signal-regulated kinase (ERK) 1/2, SAPK/JNK, and p38MAPK phosphorylation in c-Src(+/+) VSMCs. In VSMCs from c-Src(+/-) and c-Src(-/-), Ang II effects were blunted, whereas c-Src deficiency had no effect in ET-1-induced MAPK activation. Ang II but not ET-1 induced c-Src phosphorylation in c-Src(+/+) VSMCs. Activation of c-Raf, an effector of Ras, was significantly increased by ET-1 and Ang II in c-Src(+/+) VSMCs. Ang II but not ET-1-mediated c-Raf phosphorylation was inhibited by c-Src deficiency. Knockdown of Ras by siRNA inhibited both ET-1 and Ang II-induced MAPK phosphorylation. CONCLUSIONS: Our data indicate differential regulation of MAPKs by distinct G protein-coupled receptors. Whereas Ang II has an obligatory need for c-Src, ET-1 mediates its actions through a c-Src-independent Ras-Raf-dependent pathway for MAPK activation. These findings suggest that Ang II and ET-1 can activate similar signaling pathways through unrelated mechanisms. MAP kinases are an important point of convergence for Ang II and ET-1.


Assuntos
Angiotensina II/fisiologia , Endotelina-1/fisiologia , Sistema de Sinalização das MAP Quinases/fisiologia , Proteínas Monoméricas de Ligação ao GTP/fisiologia , Músculo Liso Vascular/enzimologia , Animais , Proteína Tirosina Quinase CSK , Células Cultivadas , Camundongos , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Músculo Liso Vascular/citologia , Miócitos de Músculo Liso/metabolismo , Proteínas Tirosina Quinases/fisiologia , Quinases da Família src
6.
Peptides ; 26(8): 1454-62, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16042985

RESUMO

We investigated whether gender differences in renal damage in DOCA-salt hypertension are associated with effects of ovarian hormones and/or endothelin-1 (ET-1). Renal injuries and renal pre-pro-ET-1 mRNA expression were enhanced in male and female ovariectomized (OVX) DOCA rats versus female DOCA rats. Treatment with estrogen plus progesterone or progesterone, but not estrogen alone, attenuated renal damage and pre-pro-ET-1 mRNA expression in OVX DOCA rats. The ETA antagonist BMS182874 greatly ameliorated renal damage in male and OVX DOCA rats. In conclusion, the ovarian hormones have a protective role on the renal structural alterations in female DOCA rats by modulating effects of ET-1, via ETA receptors.


Assuntos
Endotelina-1/farmacologia , Nefropatias/prevenção & controle , Rim/efeitos dos fármacos , Caracteres Sexuais , Animais , Compostos de Dansil/farmacologia , Desoxicorticosterona/antagonistas & inibidores , Desoxicorticosterona/química , Modelos Animais de Doenças , Endotelina-1/genética , Estrogênios/farmacologia , Feminino , Hidralazina/farmacologia , Hipertensão/induzido quimicamente , Hipertensão/fisiopatologia , Hipertensão/prevenção & controle , Rim/química , Rim/fisiopatologia , Nefropatias/induzido quimicamente , Nefropatias/fisiopatologia , Masculino , Ovariectomia/métodos , Progesterona/farmacologia , RNA Mensageiro/genética , Ratos , Ratos Wistar , Receptor de Endotelina A/efeitos dos fármacos , Cloreto de Sódio
7.
Hypertension ; 38(3 Pt 2): 592-6, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11566937

RESUMO

Arteries from hypertensive rats show a greater contraction in response to Ca(2+) channel activator and an increased sensitivity to Ca(2+) entry blockers compared with those of normotensive rats. These facts suggest an altered Ca(2+) influx through membrane channels. In this study, this hypothesis was tested by direct activation of voltage-gated Ca(2+) channels using Bay K 8644, a dihydropyridine sensitive large conductance (L-type) Ca(2+) channel opener in aortas from 2-kidney, 1-clip (2K1C) hypertensive rats. Because the membrane potential of smooth muscle cells is an important regulator of the conformational state of L-type Ca(2+) channels and, consequently, dihydropyridine affinity, the effect of 10 mmol/L KCl on the responses to Bay K 8644 was also studied. Maximal contraction (ME) and sensitivity to Bay K 8644 were greater in 2K1C rats than in 2K normotensive rats (ME, 1.77+/-0.15 versus 1.25+/-0.19 g; negative log molar value [pD(2)], 8.27+/-0.07 versus 7.92+/-0.08). When the KCl concentration was increased from 4.7 to 10 mmol/L in the bathing medium, no differences were observed in the contractile effect of Bay K 8644 between 2K1C and 2K (ME, 1.28+/-0.13 versus 1.14+/-0.21 g; pD(2), 8.56+/-0.08 versus 8.38+/-0.07). The cell resting membrane potential of 2K1C aorta vascular smooth muscle cells were less negative than in 2K (-35.19+/-4.91 versus -48.32+/-1.88 mV). Basal intracellular Ca(2+) concentration ([Ca(2+)](i)) was greater in cultured vascular smooth muscle cells from 2K1C than from 2K (293.4+/-25.83 versus 205.40+/-12.83 nmol/L). In 2K1C, Bay K 8644 induced a larger increase in [Ca(2+)](i) than in 2K (190.60+/-45.65 versus 92.57+/-14.67 nmol/L), and in 10 mmol/L KCl, this difference was abolished (134.90+/-45.12 versus 125.20+/-32.17 nmol/L). The main conclusion of the present work is that the increased contractile response to Bay K 8644 in 2K1C aortas is due to an increased Ca(2+) influx through voltage-gated Ca(2+) channels.


Assuntos
Aorta Torácica/metabolismo , Cálcio/metabolismo , Hipertensão Renovascular/metabolismo , Éster Metílico do Ácido 3-Piridinacarboxílico, 1,4-Di-Hidro-2,6-Dimetil-5-Nitro-4-(2-(Trifluormetil)fenil)/farmacologia , Animais , Aorta Torácica/efeitos dos fármacos , Aorta Torácica/fisiopatologia , Agonistas dos Canais de Cálcio/farmacologia , Relação Dose-Resposta a Droga , Endotélio Vascular/fisiologia , Hipertensão Renovascular/fisiopatologia , Técnicas In Vitro , Masculino , Potenciais da Membrana/efeitos dos fármacos , Músculo Liso Vascular/citologia , Músculo Liso Vascular/efeitos dos fármacos , Músculo Liso Vascular/fisiologia , Cloreto de Potássio/farmacologia , Ratos , Ratos Wistar , Vasoconstrição/efeitos dos fármacos
8.
Gen Pharmacol ; 34(6): 379-89, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11483287

RESUMO

The contribution of endothelial factors and mechanisms underlying decreased acetylcholine-induced relaxation and endothelial inhibitory action on phenylephrine-induced contraction were evaluated in aortas of two-kidney, one-clip hypertensive (2K-1C) and normotensive (2K) rats. Relaxation induced by acetylcholine in 2K-1C precontracted by phenylephrine was lower [Maximum Effect (ME): 71.33+/-3.36%; pD(2): 7.050+/-0.03] than in 2K (ME: 95.26+/-1.59%; pD(2): 7.31+/-0.07). This response was abolished by N(G)-nitro-L-arginine (L-NNA) in 2K-1C, but was only reduced in 2K (ME: 29.21+/-9.28%). Indomethacin had no effect in 2K-1C, and slightly attenuated acetylcholine-induced relaxation in 2K. The combination of L-NNA and indomethacin almost abolished acetylcholine-induced relaxation in 2K-1C, while in 2K, the inhibition (ME: 56.61+/-8.95%) was lower than the effect of L-NNA alone. During the KCl-induced precontraction, 2K and 2K-1C aortas showed similar acetylcholine-induced relaxation (43.50+/-5.64% vs. 41.60+/-4.36%), which was abolished by L-NNA. The levels of cGMP produced in response to acetylcholine were not different between 2K and 2K-1C. The sensitivity to sodium nitroprusside was lower in phenylephrine-precontracted aortas from 2K-1C than 2K, as showed by the pD(2) values (7.72+/-0.20 vs. 8.59+/-0.17), and this difference was abolished in aortas precontracted by KCl. The membrane potential was less negative in 2K-1C than in 2K (-41.57+/-1.19 vs. -51.00+/-1.13 mV) and hyperpolarization induced by acetylcholine was lower in 2K-1C than in 2K aortas (6.00+/-0.66 vs. 13.27+/-1.61 mV). Phenylephrine-induced contraction in aortas with endothelium was similar in both groups, and increased by the endothelium removal. This increase was lower in 2K-1C (from 1.32+/-0.06 to 1.90+/-0.21 g) than 2K (from 1.49+/-0.07 to 2.83+/-0.18 g). L-NNA and the endothelium removal had similar effect in 2K-1C (1.85+/-0.18 g) and were lower in 2K (2.18+/-0.20 g). Indomethacin decreased phenylephrine-induced contraction only in 2K. In conclusion, our major finding was a selective defect in smooth muscle membrane hyperpolarization, which could explain the decreased relaxation to acetylcholine and the attenuated inhibitory effect of endothelium on the contractile function in 2K-1C aortas.


Assuntos
Acetilcolina/farmacologia , Aorta/efeitos dos fármacos , Hipertensão Renovascular/fisiopatologia , Relaxamento Muscular/efeitos dos fármacos , Vasodilatadores/farmacologia , Animais , Fatores Biológicos/fisiologia , GMP Cíclico/metabolismo , Modelos Animais de Doenças , Endotélio Vascular/efeitos dos fármacos , Hipertensão Renal/fisiopatologia , Indometacina/farmacologia , Masculino , Potenciais da Membrana/efeitos dos fármacos , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Músculo Liso Vascular/efeitos dos fármacos , Fenilefrina/farmacologia , Ratos , Ratos Wistar , Estimulação Química
9.
Gen Pharmacol ; 33(6): 457-66, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10647771

RESUMO

This study examined whether alterations in intracellular or extracellular Ca2+ mobilization were related to differences in caffeine and phenylephrine (PHE)-induced contractions between two-kidney. one-clip hypertensive (2K-1C) and normotensive (2K) rat aortas. After depletion and reloading of intracellular Ca2+ stores, caffeine and PHE-induced contractions in Ca2+-free solution were increased in 2K-1C. Thapsigargin reduced the contraction to caffeine in 2K-1C and 2K with similar sensitivity. PHE-induced contraction in 1.6-mM Ca2+ solution was decreased in 2K-1C, and nifedipine was less effective in lowering this response. The responsiveness to extracellular Ca2+ was decreased in 2K-1C hypertensive rat aortas. Our results indicate an increased intracellular Ca2+ stores that are not related to alteration in Ca2+-ATPase function and a lower contribution of L-type channels to the contraction of 2K-1C aortas.


Assuntos
Aorta/efeitos dos fármacos , Canais de Cálcio Tipo L/fisiologia , Cálcio/metabolismo , Hipertensão Renal/fisiopatologia , Retículo Sarcoplasmático/metabolismo , Animais , Aorta/fisiologia , Cafeína/farmacologia , Técnicas In Vitro , Masculino , Nifedipino/farmacologia , Fenilefrina/farmacologia , Cloreto de Potássio/farmacologia , Ratos , Ratos Wistar , Tapsigargina/farmacologia , Vasoconstrição/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...